Form 4: GCM Grosvenor President Awarded 241,305 RSUs
Insider Transaction Report
GCM Grosvenor Inc. President and Director Jonathan Reisin Levin received grants of 241,305 Restricted Stock Units under the company's incentive plan.
Summary
- Jonathan Reisin Levin, President and Director of GCM Grosvenor Inc. (GCMG), was granted a total of 241,305 Restricted Stock Units (RSUs).
- The grants were made under the Issuer's Amended and Restated 2020 Incentive Award Plan on March 1, 2026.
- One grant consists of 91,305 RSUs, which will vest in full on August 15, 2026, subject to continued service.
- The second grant consists of 150,000 RSUs, which will vest in three equal installments on May 15, 2027, May 15, 2028, and May 15, 2029, also subject to continued service.
- Each RSU represents the contingent right to receive one share of Class A Common Stock.
- Delivery of Class A Common Stock for vested RSUs will occur on the delivery date specified in the award agreement; for the 91,305 RSU grant, the Issuer has the sole discretion to settle in cash or a combination of stock and cash.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with shareholder interests. It's not highly impactful but signals continued commitment.
Positives
- The RSU grants align the interests of President and Director Jonathan Reisin Levin with those of shareholders, as the value of his compensation is tied to the company's stock performance.
- Equity-based compensation serves as an incentive for long-term commitment and performance from key management personnel.
Negatives
- The future issuance of Class A Common Stock upon vesting of these RSUs could result in a degree of dilution for existing shareholders, although this is a common practice for executive compensation.
- The company will incur future compensation expense related to these RSU grants, impacting financial statements.
Risks
- The vesting of RSUs is contingent upon Jonathan Reisin Levin's continued service through the specified vesting dates, meaning the awards could be forfeited if service terminates prematurely.
- The ultimate value of the RSUs to the recipient is subject to the future market price of GCM Grosvenor Inc.'s Class A Common Stock, introducing market risk.
- For the 91,305 RSU grant, the Issuer's discretion to settle in cash or a combination of stock and cash introduces uncertainty regarding the form of settlement.
Future Outlook
The filing details the future vesting schedule for the granted Restricted Stock Units, indicating specific dates when the awards will become exercisable. It does not provide any forward-looking statements or guidance regarding the company's financial performance, strategic objectives, or broader business outlook.
Industry Context
StockSavvy.ai notes that the grant of Restricted Stock Units to a key executive like the President and Director is a standard practice in the financial services industry. Such equity awards are commonly used to attract, retain, and incentivize top talent by linking their long-term compensation directly to the company's stock performance and shareholder value creation. This aligns GCM Grosvenor Inc. with typical executive compensation structures seen across publicly traded asset management and alternative investment firms.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a form of executive compensation is a prevalent practice across the financial industry, including firms like Blackstone (BX), KKR (KKR), and Apollo Global Management (APO), which frequently utilize equity grants to incentivize their leadership.
- The vesting schedules, particularly multi-year vesting for a significant portion of the grant (150,000 RSUs over three years), are consistent with industry norms designed to promote long-term retention and performance, similar to programs at major investment banks and asset managers.
- The total number of RSUs granted (241,305) would need to be evaluated against the executive's overall compensation package and the company's market capitalization to fully assess its scale relative to peers, but the mechanism itself is standard.
Stakeholder Impact
- Shareholders: Potential for minor dilution upon RSU vesting, but also increased alignment of executive interests with shareholder value creation.
- Employees (Jonathan Reisin Levin): Significant portion of future compensation tied to company performance and continued employment, providing strong incentive.
Next Steps
- Jonathan Reisin Levin's continued service through August 15, 2026, for the first RSU grant to vest.
- Jonathan Reisin Levin's continued service through May 15, 2027, May 15, 2028, and May 15, 2029, for the second RSU grant to vest in installments.
- Delivery of Class A Common Stock (or cash/combination for the first grant) upon vesting of the RSUs.
Key Dates
| Date | Description |
|---|---|
| 03/01/2026 | Date of RSU grants under the Amended and Restated 2020 Incentive Award Plan. |
| 08/15/2026 | Vesting date for 91,305 RSUs, subject to continued service. |
| 03/03/2026 | Signature date of the Form 4 filing by Attorney-in-Fact. |
| 05/15/2027 | First vesting installment date for 150,000 RSUs (one-third), subject to continued service. |
| 05/15/2028 | Second vesting installment date for 150,000 RSUs (one-third), subject to continued service. |
| 05/15/2029 | Third and final vesting installment date for 150,000 RSUs (one-third), subject to continued service. |
Keywords
GCM Grosvenor, GCMG, Restricted Stock Units, RSU, Equity Grant, Executive Compensation, Insider Transaction, Form 4, Incentive Plan, Director Compensation, President Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.